Andere Sprachen Betta Pharmaceuticals Co., Ltd.

Aktien

300558

CNE100002DD9

300558

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 10.05.2024			% 5 Tage	% 1. Jan.
42,84 ^CNY	-3,08 %		+2,66 %	-16,90 %

19.04.	Betta Pharmaceuticals Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
2023	Betta Pharmaceuticals Co., Ltd. meldet Ergebnis für die neun Monate bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19.04.
C4 Therapeutics, Inc. announced that it has received $24.999997 million in funding from Betta Pharmaceuticals Co., Ltd.	04.01.
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24.10.23
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25.08.23
Beijing Mabworks Biotech Co., Ltd. announced that it expects to receive CNY 150.000042 million in funding from Betta Pharmaceuticals Co., Ltd.	01.08.23
C4 Therapeutics Shares Up 18% After Lung Cancer Drug Application Receives FDA Clearance	05.07.23
Betta Pharmaceuticals Gets Nod for Voronib Tablets' Listing	09.06.23
Betta Pharmaceuticals Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 15 June 2023	08.06.23
C4 Therapeutics, Betta Pharmaceuticals Sign Deal to Develop, Commercialize CFT8919 in Greater China	30.05.23
C4 Therapeutics and Betta Pharmaceuticals Announce Exclusive Licensing Agreement for the Development and Commercialization in Greater China of CFT8919, an Orally Bioavailable BiDAC Degrader of EGFR L858R for NSCLC	30.05.23
C4 Therapeutics, Inc. announced that it expects to receive $24.999997 million in funding from Betta Pharmaceuticals Co., Ltd.	30.05.23
Betta Pharmaceuticals Co., Ltd. Approves Cash Dividend for the Year of 2022	16.05.23
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27.04.23
Betta Pharmaceuticals Co., Ltd. Announces Profit Distribution Proposal for 2022	24.04.23
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23.04.23
Betta Pharmaceuticals Gets Nod to Start Clinical Trial of Tumor Drug in China	14.03.23
Betta Pharmaceuticals Co., Ltd. cancelled the transaction announced on June 13, 2022	10.01.23
Betta Pharmaceuticals Co., Ltd. Approves Board Elections	28.12.22
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28.10.22
Betta Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24.08.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Betta Pharmaceuticals Co., Ltd.

Aktien

300558

CNE100002DD9

300558

Andere Sprachen

Filter